New approaches for prevention of intravascular catheter-related infections

Infections in Medicine

Volumn 18, Issue 1, 2001, Pages 38-48

  Hanna, Hend ^a   Darouiche, Rabih ^b   Raad, Issam ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Department of Medicine ^*

Author keywords

Antimicrobial film; Catheter related; Infection

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BACTOCILL; CEFAZOLIN; CEFTAZIDIME; CEFTAZIDIME ARGININE; CEFTRIAXONE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CIPROFLOXACIN; CLINDAMYCIN; COLLAGEN; DICLOXACILLIN; ERYTHROMYCIN; FIBRIN; FIBRINOGEN; FIBRONECTIN; FLUCONAZOLE; FUSIDATE SODIUM; FUSIDIC ACID; GENTAMICIN; HEPARIN; HEPARIN CALCIUM; LAMININ; MINOCYCLINE; NAFCILLIN; OXACILLIN; PENICILLIN G; PERIOGARD; RIFAMPICIN; SULFADIAZINE SILVER; THROMBOSPONDIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTISEPSIS; BACTERIAL COLONIZATION; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; REVIEW; RISK MANAGEMENT; VASCULAR ACCESS;

EID: 0035139840     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis. 1992;15:197-210.
2. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little Brown; 1992:849-898.
3. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med. 1991;9(suppl 3B):185S-191S.
4. Maki DG, Cobb L, Garman JK, et al. An attachable silver impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med. 1988;85:307-314.
5. Heiselman D. Nosocomial bloodstream infections in the critically ill. JAMA. 1994;272:1819-1820.
6. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1994;272:1578-1601.
7. Raad II, Costerton W, Sabharwal U, et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400-407.
8. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med. 1991;92(suppl 3B):197S-205S.
9. Linares J, Sitges-Serra A, Garau J, et al. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segment. J Clin Microbiol. 1983;21:357-360.
10. Salzman MB, Isenberg HD, Shapiro JF, et al. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis. 1993;167:487-490.
11. Sitges-Serra A, Puig P, Linares J, et al. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN. 1984;8:668-672.
12. Costerton JW, Irvin RT, Cheng KR. The bacterial glycocalyx in nature and disease. Annu Rev Microbiol. 1981;35:299-324.
13. Pfaller MA, Messer SA, Hollis RJ. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn Microbiol Infect Dis. 1995;21:9-14.
14. Sheth NK, Franson TR, Sohnle PG. Influence of bacterial adherence to intravascular catheters on in vitro antibiotic susceptibility. Lancet. 1985;2:1266-1268.
15. Farber BF, Kaplan MH, Clogstron AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis. 1990;161:37-40.
16. Hawiger J, Timmons S, Strong DD, et al. Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. Biochem J. 1982;21:1407-1413.
17. Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature. 1978;276:718-720.
18. Bouali A, Robert R, Tronchin G, Senet JM. Characterization of binding of human fibrinogen to the surface of germ-tubes and mycelium of Candida albicans. J Gen Microbiol. 1987;133:545-551.
19. Raad I, Luna M, Sayed-Ahmed MK, et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA. 1994;271:1014-1016.
20. Sherertz R, Raad I, Balani A, et al. Sonication vascular catheter cultures: a 3-year experience in a clinical microbiology laboratory. J Clin Microbiol. 1990;28:76-82.
21. Strausbaugh LJ, Sewell DL, Ward TT, et al. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol. 1994;32: 2299-2300.
22. Plouffe JF, Brown DG, Silva J, et al. Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Intern Med. 1977;137:1686-1689.
23. Krzywda EA, Andris DA, Edmiston CE, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol. 1995;16:596-598.
24. Benoit J-L, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis. 1995;21:1286-1288.
25. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990;8:591-597.
26. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr. 1995;127:147-151.
27. Raad I, Buzaid A, Rhyne J, et al. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis. 1997;25:149-151.
28. Raad I, Hachem R, Sherertz R. Efficacy of minocycline/EDTA (M-EDTA) flush in preventing catheter-related bacteremia (CRB) and septic phlebitis (SP) in rabbits. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 4-7, 1994; Orlando, Fla. Abstract 157.
29. Segura M, Alia C, Oms L, et al. In vitro bacteriological study of a new hub model for intravascular catheters and infusion equipment. J Clin Microbiol. 1989;27:2656-2659.
30. Segura M, Alia C, Valverde J, et al. Assessment of a new hub design and the semiquantitative catheter culture method using an in vivo experiment model of catheter sepsis. J Clin Microbiol. 1990;28:2551-2554.
31. Segura M, Alvarez-Lerma F, Tellado JM, et al. Advances in surgical technique: a clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg. 1996;223: 363-369.
32. Flowers RH III, Schwenzer KJ, Kopel RF, et al. Efficacy of an attachable subcutaneous cuff for the prevention of intra vascular catheter-related infection. JAMA. 1989;261:878-883.
33. Clementi E, Mario O, Arlet G, et al. Usefulness of an attachable silver impregnated cuff for the prevention of catheter-related sepsis (CRS). In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy; September 29-October 2, 1991; Chicago. Abstract 460.
34. Groeger JS, Lucas AB, Coit D, et al. A prospective randomized evaluation of silver-impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg. 1993;218:206-210.
35. Raad I, Hachem R, Zermeno A, et al. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials. 1996;17:1055-1059.
36. Raad I, Hachem R, Zermeno A, et al. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J Infect Dis. 1996;173:495-498.
37. Bjornson HS, Colley R, Bower RH, et al. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Ann Surg. 1982;92:720-732.
38. Greco RS, Harvey RA. The role of antibiotics bonding in the prevention of vascular prosthetic infections. Ann Surg. 1982;195:168-171.
39. Harvey RA, Greco RS. The noncovalent bonding of antibiotics to a polytetrafluoroethylenebenzalkonium graft. Ann Surg. 1981;194:642-647.
40. Trooskin SZ, Donetz AP, Harvey RA, Greco RS. Prevention of catheter sepsis by antibiotic bonding. Ann Surg. 1984;97:547-551.
41. Sherertz RJ, Carruth WA, Hampton AA, et al. Efficacy of antibiotic coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis. 1993;167:98-106.
42. Darouiche RO, Raad I. Antimicrobial impregnated catheters and other medical implants and methods for impregnating catheters and other medical implants with an antimicrobial agent. US patent # 5 624 704. 1997.
43. Kamal GD, Pfaller MA, Rempe LE, Jebson PJR. Reduced intravascular catheter infection by antibiotic bonding. JAMA. 1991;265:2364-2368.
44. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter a randomized, controlled study. Ann Intern Med. 1997;127:257-266.
45. Ciresi D, Albrecht RM, Volkers PA, Scholten DJ. Failure of an antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg. 1996;62:641-646.
46. Pemberton LB, Ross V, Cuddy P, et al. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg. 1996;131:986-989.
47. Heard SO, Wagle M, Vijayakumar E, et al. The influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med. 1998;158:81-87.
48. Raad I, Darouiche R, Hachem R, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis. 1996;173:418-424.
49. Oda T, Junichiro H, Noami K, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology. 1997; 87:1242-1244.
50. World Health Organization. Central venous catheters (Arrowguard) recalled: anaphylactic shock. Geneva: World Health Organization; 1997. Alert 62.
51. Centers for Devices and Radiological Health. Potential hypersensitivity reactions to chlorhexidine-impregnated medical devices. Washington, DC, US. Food and Drug Administration; FDA public health notice. Available at: http://www/fda.gov/cdrh/chlorhex.html.
52. Raad I, Darouiche R, Hachem R, et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother. 1995; 39:2397-2400.
53. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999;340:1-8.
54. Raad II, Darouiche RO, Hachem R, et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med. 1998;26:219-224.